ArticleMolecular pharmaceutics2023

Discovery of a Non-competitive TNFR1 Antagonist Affibody with Picomolar Monovalent Potency That Does Not Affect TNFR2 Function.

Nagamani Vunnam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.